Eip Pharma Inc
Clinical trials sponsored by Eip Pharma Inc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a pill help restore speech in progressive aphasia? Results expected Sep 2026 (estimated)
- Could a pill boost brain recovery after stroke? new trial begins Results expected Sep 2026 (estimated)
-
Could a pill ease lewy body dementia? small trial tests safety
Disease control CompletedThis completed Phase 2a study tested an oral drug called neflamapimod in 26 people with dementia with Lewy bodies. The main goal was to check safety and how the drug moves through the body over 24 weeks. Researchers also looked at changes in thinking and memory as a secondary mea…
Phase 2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could this pill boost brain function in lewy body dementia?
Symptom relief CompletedThis study tested an experimental drug called neflamapimod in 159 people with dementia with Lewy bodies (DLB). The goal was to see if it could improve memory, problem-solving, and attention compared to a placebo. Participants took the drug or a dummy pill for a set period, and re…
Phase 2 • Sponsor: EIP Pharma Inc • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC